<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1107" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1107/" /><meta name="ncbi_pagename" content="Spastic Paraplegia 7 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spastic Paraplegia 7 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spastic Paraplegia 7" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/10/25" /><meta name="citation_author" content="Giorgio Casari" /><meta name="citation_author" content="Roberto Marconi" /><meta name="citation_pmid" content="20301286" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1107/" /><meta name="citation_keywords" content="Hereditary Spastic Paraplegia, Paraplegin Type" /><meta name="citation_keywords" content="Hereditary Spastic Paraplegia, Paraplegin Type" /><meta name="citation_keywords" content="SPG7" /><meta name="citation_keywords" content="Paraplegin" /><meta name="citation_keywords" content="SPG7" /><meta name="citation_keywords" content="Spastic Paraplegia 7" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spastic Paraplegia 7" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Giorgio Casari" /><meta name="DC.Contributor" content="Roberto Marconi" /><meta name="DC.Date" content="2018/10/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1107/" /><meta name="description" content="Spastic paraplegia 7 (SPG7) is characterized by insidiously progressive bilateral leg weakness and spasticity. Most affected individuals have decreased vibration sense and cerebellar signs. Onset is mostly in adulthood, although symptoms may start as early as age 11 years and as late as age 72 years. Additional features including ataxia (gait and limbs), spastic dysarthria, dysphagia, pale optic disks, ataxia, nystagmus, strabismus, ptosis, hearing loss, motor and sensory neuropathy, amyotrophy, scoliosis, pes cavus, and urinary sphincter disturbances may be observed." /><meta name="og:title" content="Spastic Paraplegia 7" /><meta name="og:type" content="book" /><meta name="og:description" content="Spastic paraplegia 7 (SPG7) is characterized by insidiously progressive bilateral leg weakness and spasticity. Most affected individuals have decreased vibration sense and cerebellar signs. Onset is mostly in adulthood, although symptoms may start as early as age 11 years and as late as age 72 years. Additional features including ataxia (gait and limbs), spastic dysarthria, dysphagia, pale optic disks, ataxia, nystagmus, strabismus, ptosis, hearing loss, motor and sensory neuropathy, amyotrophy, scoliosis, pes cavus, and urinary sphincter disturbances may be observed." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1107/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/spg7/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1107/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B4E12E03FA791000000000A2F03B8.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1107_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1107_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spg4/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spg8/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1107_"><span class="title" itemprop="name">Spastic Paraplegia 7</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Hereditary Spastic Paraplegia, Paraplegin Type</div><p class="contrib-group"><span itemprop="author">Giorgio Casari</span>, PhD and <span itemprop="author">Roberto Marconi</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1107_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1107_ai__"><div class="contrib half_rhythm"><span itemprop="author">Giorgio Casari</span>, PhD<div class="affiliation small">San Raffaele University<br />Milan, Italy</div><div class="affiliation small">Telethon Institute of Genetics and Medicine<br />Pozzuoli, Naples, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.rsh@oigroig.irasac" class="oemail">ti.rsh@oigroig.irasac</a><span style="unicode-bidi: bidi-override; direction: ltr;">; </span><a href="mailto:dev@null" data-email="ti.megit@irasac" class="oemail">ti.megit@irasac</a><div></div></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Roberto Marconi</span>, MD<div class="affiliation small">Cardio-Neurovascular Department - Neurologic Unit<br />National Health System<br />Toscana Sud Est<br />Ospedale Misericordia<br />Grosseto, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.anacsot.tseduslsu@inocram.otrebor" class="oemail">ti.anacsot.tseduslsu@inocram.otrebor</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 24, 2006</span>; Last Update: <span itemprop="dateModified">October 25, 2018</span>.</p><p><em>Estimated reading time: 15 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="spg7.Summary" itemprop="description"><h2 id="_spg7_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Spastic paraplegia 7 (SPG7) is characterized by insidiously progressive bilateral leg weakness and spasticity. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have decreased vibration sense and cerebellar signs. Onset is mostly in adulthood, although symptoms may start as early as age 11 years and as late as age 72 years. Additional features including ataxia (gait and limbs), spastic dysarthria, dysphagia, pale optic disks, ataxia, nystagmus, strabismus, ptosis, hearing loss, motor and sensory neuropathy, amyotrophy, scoliosis, <i>pes cavus</i>, and urinary sphincter disturbances may be observed.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SPG7 is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SPG7</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Drugs that may reduce spasticity and muscle tightness include baclofen, tizanidine, dantrolene, and diazepam. Physical therapy and assistive walking devices often reduce contractures, provide support, and promote stability. Occupational therapy and speech therapy help with activities of daily living.</p><p><i>Surveillance:</i> Annual neurologic evaluation to identify potential complications of spasticity, such as contractures.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SPG7 is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Heterozygotes (carriers) are usually asymptomatic. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for pregnancies at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible if both pathogenic alleles have been identified in the family.</p></div></div><div id="spg7.Diagnosis"><h2 id="_spg7_Diagnosis_">Diagnosis</h2><div id="spg7.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Spastic paraplegia 7 (SPG7) <b>should be suspected</b> in individuals with the following:</p><ul><li class="half_rhythm"><div>Insidiously progressive bilateral leg weakness</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Decreased vibratory sense</div></li><li class="half_rhythm"><div>Cerebellar signs</div></li><li class="half_rhythm"><div>Neurologic examination demonstrating EITHER of the following:</div><ul><li class="half_rhythm"><div>A pure <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of spastic paraplegia with hyperreflexia, extensor plantar responses, and mildly impaired vibration sensation in the distal legs</div></li><li class="half_rhythm"><div>A complicated <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of spastic paraplegia including optic neuropathy, progressive external ophthalmoplegia/ptosis slowed speech, swallowing difficulties, palatal tremor, subtle cognitive impairment, urinary urgency, ataxia, nystagmus, strabismus, decreased hearing, scoliosis, <i>pes cavus</i>, motor and sensory neuropathy, and amyotrophy [<a class="bk_pop" href="#spg7.REF.brugman.2008.1500">Brugman et al 2008</a>, <a class="bk_pop" href="#spg7.REF.salinas.2008.1127">Salinas et al 2008</a>, <a class="bk_pop" href="#spg7.REF.warnecke.2010.413">Warnecke et al 2010</a>, <a class="bk_pop" href="#spg7.REF.pfeffer.2014.1323">Pfeffer et al 2014</a>]</div></li></ul></li><li class="half_rhythm"><div>Neuroimaging findings of cerebellar atrophy (MRI) or white matter changes as detected by diffusion tensor imaging in the frontal lobes, the corticospinal tracts, and the brain stem</div></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul></div><div id="spg7.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SPG 7 <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical clinical findings and identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>SPG7</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1107/table/spg7.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figspg7Tmoleculargenetictestingusedin" rid-ob="figobspg7Tmoleculargenetictestingusedin">Table 1</a>).</p><p>Note: A single <i>SPG7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (p.Leu78*) was identified in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a pure HSP <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> suggesting that heterozygosity for an <i>SPG7</i> pathogenic variant may be sufficient to cause disease (i.e., <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance). However, this conclusion is challenged by the finding of unaffected p.Leu78* heterozygotes in other families as well as the possibility that the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> individual had a second <i>SPG7</i> pathogenic variant which was not detected due to testing limitations [<a class="bk_pop" href="#spg7.REF.s_nchezferrero.2013.257">S&#x000e1;nchez-Ferrero et al 2013</a>].</p><p>Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SPG7 is indistinguishable from many other forms of hereditary spastic paraplegia, recommended <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches include use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> or <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>.</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SPG7,</i> followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SPG7</i> and other genes of interest (see <a href="#spg7.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1107/table/spg7.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figspg7Tmoleculargenetictestingusedin" rid-ob="figobspg7Tmoleculargenetictestingusedin">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is another good option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. Exome array (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="spg7.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Spastic Paraplegia 7</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1107/table/spg7.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg7.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPG7</i></td><td headers="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;98%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_spg7.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;2%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="spg7.TF.1.1"><p class="no_margin">See <a href="/books/NBK1107/#spg7.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="spg7.TF.1.2"><p class="no_margin">See <a href="#spg7.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="spg7.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="spg7.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#spg7.REF.arnoldi.2008.522">Arnoldi et al [2008]</a>, <a class="bk_pop" href="#spg7.REF.brugman.2008.1500">Brugman et al [2008]</a>, <a class="bk_pop" href="#spg7.REF.klebe.2012.2980">Klebe et al [2012]</a>, <a class="bk_pop" href="#spg7.REF.van_gassen.2012.2994">van Gassen et al [2012]</a>, <a class="bk_pop" href="#spg7.REF.s_nchezferrero.2013.257">S&#x000e1;nchez-Ferrero et al [2013]</a>, <a class="bk_pop" href="#spg7.REF.pfeffer.2015.1174">Pfeffer et al [2015]</a></p></div></dd><dt>5. </dt><dd><div id="spg7.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="spg7.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#spg7.REF.casari.1998.973">Casari et al [1998]</a>, <a class="bk_pop" href="#spg7.REF.arnoldi.2008.522">Arnoldi et al [2008]</a>, <a class="bk_pop" href="#spg7.REF.klebe.2012.2980">Klebe et al [2012]</a>, <a class="bk_pop" href="#spg7.REF.van_gassen.2012.2994">van Gassen et al [2012]</a>, <a class="bk_pop" href="#spg7.REF.s_nchezferrero.2013.257">S&#x000e1;nchez-Ferrero et al [2013]</a></p></div></dd></dl></div></div></div></div></div><div id="spg7.Clinical_Characteristics"><h2 id="_spg7_Clinical_Characteristics_">Clinical Characteristics</h2><div id="spg7.Clinical_Description"><h3>Clinical Description</h3><p>Spastic paraplegia 7 (SPG7) is characterized by insidiously progressive bilateral lower-limb weakness and spasticity. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have proximal or generalized weakness in the legs and impaired vibration sense.</p><p><b>Onset</b> typically occurs in adulthood, around age 30-45 years, although symptoms may start as early as age 11 years and as late as age 72 years [<a class="bk_pop" href="#spg7.REF.de_michele.1998.135">De Michele et al 1998</a>, <a class="bk_pop" href="#spg7.REF.mcdermott.2001.467">McDermott et al 2001</a>, <a class="bk_pop" href="#spg7.REF.wilkinson.2004.973">Wilkinson et al 2004</a>].</p><p><b>Presentation</b>. The first sign is typically insidiously progressive bilateral leg weakness.</p><p><b>Additional features.</b> Other signs and symptoms can be observed [<a class="bk_pop" href="#spg7.REF.brugman.2008.1500">Brugman et al 2008</a>, <a class="bk_pop" href="#spg7.REF.salinas.2008.1127">Salinas et al 2008</a>, <a class="bk_pop" href="#spg7.REF.warnecke.2010.413">Warnecke et al 2010</a>, <a class="bk_pop" href="#spg7.REF.almontashiri.2014.834">Almontashiri et al 2014</a>, <a class="bk_pop" href="#spg7.REF.pfeffer.2014.1323">Pfeffer et al 2014</a>] including the following:</p><ul><li class="half_rhythm"><div>Cerebellar and motor signs</div><ul><li class="half_rhythm"><div>Ataxia (gait and limbs)</div></li><li class="half_rhythm"><div>Spastic dysarthria</div></li><li class="half_rhythm"><div>Dysphagia</div></li></ul></li><li class="half_rhythm"><div>Ophthalmic findings</div><ul><li class="half_rhythm"><div>Pale optic disks</div></li><li class="half_rhythm"><div>Nystagmus</div></li><li class="half_rhythm"><div>Strabismus</div></li><li class="half_rhythm"><div>Ptosis</div></li></ul></li><li class="half_rhythm"><div>Hearing loss of conductive/neurosensory /mixed type</div></li><li class="half_rhythm"><div>Peripheral neuromuscular findings</div><ul><li class="half_rhythm"><div>Motor and sensory neuropathy</div></li><li class="half_rhythm"><div>Amyotrophy</div></li></ul></li><li class="half_rhythm"><div>Orthopedic issues</div><ul><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div><i>Pes cavus</i></div></li></ul></li><li class="half_rhythm"><div>Urinary sphincter disturbances</div></li></ul><p><b>Progression.</b> Severe disability of gait due to leg spasticity may develop as soon as eight years after onset of symptoms, and some individuals are confined to a wheelchair [<a class="bk_pop" href="#spg7.REF.elleuch.2006.654">Elleuch et al 2006</a>, <a class="bk_pop" href="#spg7.REF.sch_le.2006.430">Sch&#x000fc;le et al 2006</a>].</p></div><div id="spg7.Findings_on_Neuroimaging_and_Other"><h3>Findings on Neuroimaging and Other Investigations</h3><p><b>Neuroimaging</b></p><ul><li class="half_rhythm"><div>In a few individuals, conventional cerebral MRI may show cerebellar (or, less frequently, cortical) atrophy [<a class="bk_pop" href="#spg7.REF.salinas.2008.1127">Salinas et al 2008</a>, <a class="bk_pop" href="#spg7.REF.hourani.2009.936">Hourani et al 2009</a>, <a class="bk_pop" href="#spg7.REF.warnecke.2010.413">Warnecke et al 2010</a>].</div></li><li class="half_rhythm"><div>White matter changes as detected by diffusion tensor imaging in the frontal lobes, the corticospinal tracts, and the brain stem are specific to SPG7.</div></li><li class="half_rhythm"><div>Spinal imaging studies are useful in the differential diagnosis to exclude other anomalies of the pontomedullary junction and of the cervical and dorsolumbar medulla.</div></li></ul><p><b>Other investigations</b></p><ul><li class="half_rhythm"><div>Spinal evoked potentials may reveal delayed prolongation of the central conduction time [<a class="bk_pop" href="#spg7.REF.nielsen.2001.335">Nielsen et al 2001</a>].</div></li><li class="half_rhythm"><div>Electromyography with nerve conduction velocities may reveal axonal sensory motor neuropathy.</div></li><li class="half_rhythm"><div>Paired transcranial magnetic stimulation may show delayed prolongation of the central motor conduction time and motor threshold in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in lower limb muscles [<a class="bk_pop" href="#spg7.REF.warnecke.2010.413">Warnecke et al 2010</a>]. Intracortical inhibition appears normal in SPG7 [<a class="bk_pop" href="#spg7.REF.nardone.2003.234">Nardone &#x00026; Tezzon 2003</a>].</div></li><li class="half_rhythm"><div>Optical coherence tomography is useful for detecting subclinical optic neuropathy [<a class="bk_pop" href="#spg7.REF.klebe.2012.2980">Klebe et al 2012</a>].</div></li><li class="half_rhythm"><div>A battery of neuropsychological tests may reveal mild impairment of visuoconstructive and executive functions in some individuals [<a class="bk_pop" href="#spg7.REF.warnecke.2010.413">Warnecke et al 2010</a>].</div></li><li class="half_rhythm"><div>Serum creatine kinase activity may be slightly above the normal range in some cases.</div></li><li class="half_rhythm"><div>Muscle biopsy has revealed the following:</div><ul><li class="half_rhythm"><div>Changes of denervation with partial reinnervation</div></li><li class="half_rhythm"><div>Atrophic, angulated fibers, predominantly type II</div></li><li class="half_rhythm"><div>Ragged-red fibers, which are positive for the histoenzymatic reaction to succinate dehydrogenase and negative for cytochrome <i>c</i> oxidase (COX, the complex IV of the mitochondrial respiratory chain), indicating an oxidative phosphorylation defect [<a class="bk_pop" href="#spg7.REF.casari.1998.973">Casari et al 1998</a>, <a class="bk_pop" href="#spg7.REF.mcdermott.2001.467">McDermott et al 2001</a>, <a class="bk_pop" href="#spg7.REF.wilkinson.2004.973">Wilkinson et al 2004</a>, <a class="bk_pop" href="#spg7.REF.tzoulis.2008.1142">Tzoulis et al 2008</a>].</div></li></ul></li></ul></div><div id="spg7.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> can be proposed based on published studies.</p></div><div id="spg7.Prevalence"><h3>Prevalence</h3><p>The prevalence of SPG7 is estimated at between 1:100,000 and 9:100,000 for most countries (<a href="http://www.orpha.net/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.orpha.net</a>).</p></div></div><div id="spg7.Genetically_Related_Allelic_Disorde"><h2 id="_spg7_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p><b>Primary lateral sclerosis (PLS).</b> Compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>SPG7</i> were reported as cosegregating with PLS in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner in five individuals from the same family [<a class="bk_pop" href="#spg7.REF.yang.2016.e60">Yang et al 2016</a>].</p><p><b>Amyotrophic lateral sclerosis (ALS).</b> Four individuals with nonfamilial ALS were found to <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>SPG7</i> [<a class="bk_pop" href="#spg7.REF.kr_ger.2016.92">Kr&#x000fc;ger et al 2016</a>].</p><p><a href="/books/n/gene/ataxias/"><b>Spinocerebellar ataxia</b></a>
<b>(SCA).</b> It is often difficult to clinically discriminate between hereditary spastic paraplegia (HSP) and SCA as the disorders can share multiple features. Several <i>SPG7</i> pathogenic variants have been reported to be associated with an ataxia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#spg7.REF.pfeffer.2015.1174">Pfeffer et al 2015</a>, <a class="bk_pop" href="#spg7.REF.choquet.2016.1016">Choquet et al 2016</a>, <a class="bk_pop" href="#spg7.REF.synofzik.2017.332">Synofzik &#x00026; Schule 2017</a>].</p></div><div id="spg7.Differential_Diagnosis"><h2 id="_spg7_Differential_Diagnosis_">Differential Diagnosis</h2><p>No significant differences exist between spastic paraplegia 7 (SPG7) and other types of pure <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic paraplegia [<a class="bk_pop" href="#spg7.REF.fink.2002.711">Fink 2002</a>, <a class="bk_pop" href="#spg7.REF.fink.2003.1045">Fink 2003</a>, <a class="bk_pop" href="#spg7.REF.salinas.2008.1127">Salinas et al 2008</a>] (see <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a> for a review). However, <a class="bk_pop" href="#spg7.REF.brugman.2008.1500">Brugman et al [2008]</a> reported that <i>SPG7</i> pathogenic variants are less likely to be found in adult-onset cases in which upper motor neuron symptoms (UMN) are present in the arms and in adult-onset cases with UMN symptoms involving the bulbar region.</p><p>Other conditions that need to be considered in the differential diagnosis of SPG7 are summarized in <a class="figpopup" href="/books/NBK1107/table/spg7.T.other_disorders_to_consider_in_th/?report=objectonly" target="object" rid-figpopup="figspg7Totherdisorderstoconsiderinth" rid-ob="figobspg7Totherdisorderstoconsiderinth">Table 2</a>.</p><div id="spg7.T.other_disorders_to_consider_in_th" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Disorders to Consider in the Differential Diagnosis of SPG7</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1107/table/spg7.T.other_disorders_to_consider_in_th/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg7.T.other_disorders_to_consider_in_th_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of This Disorder</th></tr><tr><th headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4" id="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/SPG7</th><th headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4" id="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from SPG7</th></tr></thead><tbody><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/x-ald/">Adrenomyeloneuropathy</a><br />and other leukodystrophies<br />(e.g., <a href="/books/n/gene/krabbe/">Krabbe disease</a>,<br /><a href="/books/n/gene/mld/">arylsulfatase A deficiency</a><br />[metachromatic<br />leukodystrophy])</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCD1</i><br /><i>GALC</i><br /><i>ARSA</i></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL<br />AR</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paraplegia neuropathy</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dementia</div></li><li class="half_rhythm"><div>On MRI: leukodystrophy, adrenal dysfunction, long-chain fatty acid accumulation</div></li></ul>
</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sca28/">Spinocerebellar ataxia type 28</a></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AFG3L2</i></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Paraplegia</div></li><li class="half_rhythm"><div>Ataxia</div></li></ul>
</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare dystonia or parkinsonism</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/drd/">Dopa-responsive dystonia</a></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCH1</i></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Brisk reflexes</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Extensor plantar responses</div></li></ul>
</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Young-onset dystonia parkinsonism responsive to levodopa</div></li><li class="half_rhythm"><div>Diurnal variation</div></li></ul>
</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/als-overview/">Amyotrophic lateral sclerosis</a></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 1</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR<br />XL</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spasticity</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Muscle atrophy, weakness &#x00026; fasciculations</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Primary lateral sclerosis&#x000a0;<sup>2</sup></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spasticity</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Survival 15-20 years</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/arg1/">Arginase deficiency</a></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARG1</i></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spasticity</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Epileptic seizures</div></li><li class="half_rhythm"><div>Severe mental retardation</div></li><li class="half_rhythm"><div>Elevated plasma arginine</div></li><li class="half_rhythm"><div>Hyperammonemia</div></li></ul>
</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Structural abnormalities of the brain or spinal cord</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gait difficulties</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">On MRI: spine abnormalities</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Vitamin B<sub>12</sub> deficiency</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unsteady gait</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Subacute combined degeneration</div></li><li class="half_rhythm"><div>Improvement after vitamin B<sub>12</sub> supplementation</div></li></ul>
</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Primary progressive multiple sclerosis</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spasticity</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>MRI white matter changes</div></li><li class="half_rhythm"><div>Oligoclonal IgG bands</div></li><li class="half_rhythm"><div>Elevated IgG index</div></li></ul>
</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive external ophthalmoplegia</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Various</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Eyelid ptosis</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>External ophthalmoplegia</div></li><li class="half_rhythm"><div>Proximal myopathy</div></li><li class="half_rhythm"><div>No pyramidal signs</div></li></ul>
</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tropical spastic paraplegia (caused by HTLV1 infection)</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">N/A</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paraplegia</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">HTLV-1 serology</td></tr><tr><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Optic neuropathy</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KLC2</i>&#x000a0;<sup>3</sup><br /><i>MFN2</i>&#x000a0;<sup>4</sup></td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />AD</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pale optic disks</td><td headers="hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_1_4 hd_h_spg7.T.other_disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No pyramidal signs</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; N/A = not applicable; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="spg7.TF.2.1"><p class="no_margin">See <a href="https://omim.org/phenotypicSeries/PS105400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Phenotypic Series: Amyotrophic lateral sclerosis</a> for a list of genes associated with this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in OMIM.</p></div></dd><dt>2. </dt><dd><div id="spg7.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#spg7.REF.brugman.2008.1500">Brugman et al [2008]</a></p></div></dd><dt>3. </dt><dd><div id="spg7.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#spg7.REF.melo.2015.6877">Melo et al [2015]</a></p></div></dd><dt>4. </dt><dd><div id="spg7.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#spg7.REF.z_chner.2006.276">Z&#x000fc;chner et al [2006]</a></p></div></dd></dl></div></div></div></div><div id="spg7.Management"><h2 id="_spg7_Management_">Management</h2><div id="spg7.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with spastic paraplegia 7 (SPG7), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Ophthalmologic evaluation</div></li><li class="half_rhythm"><div>Hearing testing</div></li><li class="half_rhythm"><div>Urologic evaluation in case of bladder dysfunction</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul><p>Evaluation by a multidisciplinary team that includes a general practitioner, neurologist, physical therapist, social worker, and psychologist should be considered.</p><p>Neuropsychological testing may be suggested.</p></div><div id="spg7.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>No specific drug treatments or cures for SPG7 exist.</p><p>Drugs to reduce spasticity and muscle tightness include baclofen, tizanidine, dantrolene, and diazepam &#x02013; preferably administered one at a time.</p><p>Management of spasticity by intrathecal baclofen or intramuscular botulinum toxin injections may be an option in selected individuals [<a class="bk_pop" href="#spg7.REF.kawano.2018.996">Kawano et al 2018</a>].</p><p>A combination of physical therapy and assistive walking devices are often used to reduce contractures, provide support, and promote stability.</p><p>Occupational therapy and speech therapy are often helpful in managing activities of daily living.</p></div><div id="spg7.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>Because individuals with advanced disease are bedridden they are at major risk of aspiration pneumonia, urinary tract infections and pulmonary embolism; careful monitoring is recommended to help avoid these complications.</p></div><div id="spg7.Surveillance"><h3>Surveillance</h3><p>Annual neurologic evaluation can help identify potential complications of spasticity that develop over time (e.g., contractures).</p></div><div id="spg7.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#spg7.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="spg7.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="spg7.Genetic_Counseling"><h2 id="_spg7_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="spg7.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Spastic paraplegia 7 (SPG7) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="spg7.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>SPG7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Findings of a subtle reduction of white matter integrity in the corpus callosum on diffusion tensor imaging have been reported in individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>SPG7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#spg7.REF.warnecke.2010.413">Warnecke et al 2010</a>] and a single possibly <a class="def" href="/books/n/gene/glossary/def-item/manifesting-heterozygote/">manifesting heterozygote</a> has been reported [<a class="bk_pop" href="#spg7.REF.s_nchezferrero.2013.257">S&#x000e1;nchez-Ferrero et al 2013</a>]. However, heterozygotes are typically not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and typically are not at risk of developing the disorder (see <b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with SPG7 are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SPG7</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>SPG7</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="spg7.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SPG7</i> pathogenic variants in the family.</p></div><div id="spg7.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="spg7.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SPG7</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for SPG7 are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="spg7.Resources"><h2 id="_spg7_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>HSP Research Foundation</b></div><div>P.O. Box 4064</div><div>Warrimoo New South Wales NSW 2774</div><div>Australia</div><div><a href="https://www.hspersunite.org.au/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hspersunite.org.au</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Hereditary-Spastic-Paraplegia-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Spastic Paraplegia Information Page</a></div></li><li class="half_rhythm"><div><b>Spastic Paraplegia Foundation, Inc.</b></div><div>7700 Leesburg Pike</div><div>Ste 123</div><div>Falls Church VA 22043</div><div><b>Phone:</b> 877-773-4483 (toll-free)</div><div><b>Email:</b> information@sp-foundation.org</div><div><a href="http://sp-foundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">sp-foundation.org</a></div></li><li class="half_rhythm"><div><b>Tom Wahlig-Foundation</b></div><div>Tom Wahlig Stiftung</div><div>B&#x000fc;ro Veghestrasse 22</div><div>Germany</div><div><b>Phone:</b> 49 (0) 251 - 20 07 91 20</div><div><b>Email:</b> nfo@hsp-info.de</div><div><a href="http://www.hsp-info.de/en/foundation.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hsp-info.de/en/foundation.htm</a></div></li><li class="half_rhythm"><div><b>A.I. Vi.P.S.</b></div><div>Associazione Italiana Vivere la Paraparesi Spastica Onlus</div><div>Via Tevere, 7</div><div>20020 Lainate (MI)</div><div>Italy</div><div><b>Phone:</b> 39 392 9825622</div><div><b>Email:</b> nfo@vipsonlus.it</div><div><a href="http://www.vipsonlus.it/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.vipsonlus.it</a></div></li></ul></div><div id="spg7.Molecular_Genetics"><h2 id="_spg7_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="spg7.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spastic Paraplegia 7: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1107/table/spg7.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg7.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_spg7.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_spg7.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_spg7.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_spg7.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_spg7.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_spg7.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_spg7.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6687" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SPG7</i></a></td><td headers="hd_b_spg7.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6687" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_spg7.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9UQ90" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Paraplegin</a></td><td headers="hd_b_spg7.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://alsod.iop.kcl.ac.uk/Als/Overview/gene.aspx?gene_id=SPG7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">alsod/SPG7 genetic mutations</a><br /><a href="http://reseq.biosciencedbc.jp/resequence/GeneDetail.do?targetId=9&#x00026;geneId=EG6687" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HSP mutation database (SPG7)</a><br /><a href="http://databases.lovd.nl/shared/genes/SPG7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPG7 database</a></td><td headers="hd_b_spg7.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SPG7" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPG7</a></td><td headers="hd_b_spg7.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SPG7[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SPG7</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="spg7.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="spg7.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spastic Paraplegia 7 (<a href="/omim/602783,607259" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1107/table/spg7.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg7.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602783" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602783</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPG7 GENE; SPG7</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607259" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607259</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>SPG7</i> spans a physical distance of approximately 52 kb and comprises 17 exons. See <a href="/books/NBK1107/#spg7.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants have been observed throughout <i>SPG7</i>. Missense variants occur most frequently. Missense and truncating variants, such as c.1454_1462del9 (reported as c.1450_1458del9 [<a class="bk_pop" href="#spg7.REF.mcdermott.2001.467">McDermott et al 2001</a>]), <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 9.5 kb [<a class="bk_pop" href="#spg7.REF.casari.1998.973">Casari et al 1998</a>] and 2228insA [<a class="bk_pop" href="#spg7.REF.casari.1998.973">Casari et al 1998</a>] have been reported to delete main protein functional domains.</p><p>Twenty-seven pathogenic variants have been reported in <i>SPG7</i> [<a class="bk_pop" href="#spg7.REF.casari.1998.973">Casari et al 1998</a>, <a class="bk_pop" href="#spg7.REF.arnoldi.2008.522">Arnoldi et al 2008</a>, <a class="bk_pop" href="#spg7.REF.brugman.2008.1500">Brugman et al 2008</a>, <a class="bk_pop" href="#spg7.REF.klebe.2012.2980">Klebe et al 2012</a>, <a class="bk_pop" href="#spg7.REF.van_gassen.2012.2994">van Gassen et al 2012</a>, <a class="bk_pop" href="#spg7.REF.s_nchezferrero.2013.257">S&#x000e1;nchez-Ferrero et al 2013</a>, <a class="bk_pop" href="#spg7.REF.pfeffer.2015.1174">Pfeffer et al 2015</a>]. The <i>SPG7</i> c.1529C&#x0003e;T (p.Ala510Val) variant is the most frequent variant found across populations [<a class="bk_pop" href="#spg7.REF.s_nchezferrero.2013.257">S&#x000e1;nchez-Ferrero et al 2013</a>, <a class="bk_pop" href="#spg7.REF.pfeffer.2015.1174">Pfeffer et al 2015</a>, <a class="bk_pop" href="#spg7.REF.choquet.2016.1016">Choquet et al 2016</a>]. Although this variant and most others identified have been associated with an ataxic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, recent efforts have focused on associating <i>SPG7</i> variants with additional clinical features. Recent studies suggest that cerebellar ataxia is a frequent feature among individuals with <i>SPG7</i>-related disease [<a class="bk_pop" href="#spg7.REF.pfeffer.2015.1174">Pfeffer et al 2015</a>, <a class="bk_pop" href="#spg7.REF.synofzik.2017.332">Synofzik &#x00026; Schule 2017</a>]. The ataxic syndrome could even be a predominant feature over spasticity, as observed in a Japanese family segregating p.Arg398Ter [<a class="bk_pop" href="#spg7.REF.yahikozawa.2015.15012">Yahikozawa et al 2015</a>].</p><div id="spg7.T.spg7_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>SPG7</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1107/table/spg7.T.spg7_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__spg7.T.spg7_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias)&#x000a0;<sup>1</sup></th><th id="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">del9.5 kb</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003119.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003119<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_003110.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003110<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1053dupC</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1192C&#x0003e;T</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg398Ter</td></tr><tr><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1454_1462del9</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg485_Glu487del</td></tr><tr><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1529C&#x0003e;T</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala510Val</td></tr><tr><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2102A&#x0003e;C</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.His701Pro</td></tr><tr><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2216insA<br />(2228insA&#x000a0;<sup>2</sup>)</td><td headers="hd_h_spg7.T.spg7_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="spg7.TF.3.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="spg7.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#spg7.REF.casari.1998.973">Casari et al [1998]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Paraplegin is a mitochondrial inner membrane protein that exerts protein quality control in a high molecular complex with AFG3L2. Both paraplegin and AFG3L2 belong to the AAA protein family (ATPases associated with diverse cellular activities) (see also <a href="/books/n/gene/hsp/">Hereditary Spastic Paraplegia Overview</a>). Paraplegin and AFG3L2 coassemble in the mitochondrial inner membrane, forming a high molecular-weight complex [<a class="bk_pop" href="#spg7.REF.atorino.2003.777">Atorino et al 2003</a>]. Paraplegin is ubiquitously expressed in adult and fetal human tissues. The presence of two hydrophobic regions, which have the characteristics of transmembrane domains, allows identification of both paraplegin and AFG3L2 as integral membrane proteins. The AAA <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is in the central part of paraplegin between amino acid residues 344 and 534, while a coil-coil domain in the carboxy-terminal part of the molecule promotes assembly in the hexameric complex. In order to achieve maturation, paraplegin undergoes several cleavages upon its import in the mitochondria inner membrane by the mitochondrial processing peptidase and by the m-AAA protease complex itself [<a class="bk_pop" href="#spg7.REF.koppen.2009.4216">Koppen et al 2009</a>]. Thus, the final processing of paraplegin in a mature form depends on its coassembly with AFG3L2 and, as recently demonstrated, the un-phosphorylation of AFG3L2 in position p.Tyr179 [<a class="bk_pop" href="#spg7.REF.almontashiri.2014.834">Almontashiri et al 2014</a>].</p><p>In a recent paper paraplegin was identified as a molecular component/regulator of the mitochondrial permeability transition pore [<a class="bk_pop" href="#spg7.REF.shanmughapriya.2015.47">Shanmughapriya et al 2015</a>]; however another study demonstrated conflicting results [<a class="bk_pop" href="#spg7.REF.k_nig.2016.148">K&#x000f6;nig et al 2016</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Inactivation of the paraplegin-AFG3L2 complex causes reduced complex I activity in mitochondria. Loss of AFG3L2 function is associated with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> spastic ataxia 5 and spinocerebellar ataxia 28 (see <a href="#spg7.Differential_Diagnosis">Differential Diagnosis</a>).</p><p>Biochemical analysis from two individuals with confirmed <i>SPG7</i> pathogenic variants revealed a reduction in citrate synthase-corrected complex I and complex II/III activities in muscle and complex I activity in mitochondrial-enriched fractions from cultured myoblasts. Mitochondrial DNA damage has been observed in muscle biopsies of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <i>SPG7</i> variants c.2102A&#x0003e;C and c.1053dupC [<a class="bk_pop" href="#spg7.REF.tzoulis.2008.1142">Tzoulis et al 2008</a>, <a class="bk_pop" href="#spg7.REF.wedding.2014.e86340">Wedding et al 2014</a>]. Further studies should clarify how paraplegin can alter mitochondrial DNA; however, this could be an indirect effect of the dysfunction of the mAAA-protease complex, as paraplegin does not interact directly with the DNA.</p><p>In mouse, <i>AFG3L2</i> <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants appear more severe than paraplegin variants; null or <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> <i>Afg3l2</i> mouse models developed marked impairment of axonal development leading to neonatal death [<a class="bk_pop" href="#spg7.REF.maltecca.2008.2827">Maltecca et al 2008</a>]. The mice developed a severe early-onset tetraparesis and were found to have reduced myelinated fibers in the spinal cord and impaired respiratory chain complex I and III activity. The increased severity of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is explained by the higher neuronal expression of AFG3L2, but also the ability of AFG3L2 to form homocomplexes, while paraplegin requires coassembly with AFG3L2 to form functional complexes. Heterozygous pathogenic variants of <i>AFG3L2</i> have been associated with a dominant form of spinocerebellar ataxia (<a href="/books/n/gene/sca28/">SCA28</a>) [<a class="bk_pop" href="#spg7.REF.di_bella.2010.313">Di Bella et al 2010</a>].</p><p><b>Gene expression regulation.</b>
<i>SPG7</i> is one of the targets of miR-224, which is located in an <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> of the GABA A receptor &#x003b5; subunit (GABRE) and produced in several models of cancer proliferation [<a class="bk_pop" href="#spg7.REF.fu.2016.421">Fu et al 2016</a>].</p></div><div id="spg7.References"><h2 id="_spg7_References_">References</h2><div id="spg7.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.almontashiri.2014.834">Almontashiri NA, Chen HH, Mailloux RJ, Tatsuta T, Teng AC, Mahmoud AB, Ho T, Stewart NA, Rippstein P, Harper ME, Roberts R, Willenborg C, Erdmann J, Pastore A, McBride HM, Langer T, Stewart AF, et al.  SPG7 variant escapes phosphorylation-regulated processing by AFG3L2, elevates mitochondrial ROS, and is associated with multiple clinical phenotypes. <span><span class="ref-journal">Cell Rep. </span>2014;<span class="ref-vol">7</span>:834–47.</span> [<a href="/pubmed/24767997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24767997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.arnoldi.2008.522">Arnoldi A, Tonelli A, Crippa F, Villani G, Pacelli C, Sironi M, Pozzoli U, D'Angelo MG, Meola G, Martinuzzi A, Crimella C, Redaelli F, Panzeri C, Renieri A, Comi GP, Turconi AC, Bresolin N, Bassi MT. A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:522–31.</span> [<a href="/pubmed/18200586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18200586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.atorino.2003.777">Atorino L, Silvestri L, Koppen M, Cassina L, Ballabio A, Marconi R, Langer T, Casari G. Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. <span><span class="ref-journal">J Cell Biol. </span>2003;<span class="ref-vol">163</span>:777–87.</span> [<a href="/pmc/articles/PMC2173682/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2173682</span></a>] [<a href="/pubmed/14623864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14623864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.brugman.2008.1500">Brugman F, Scheffer H, Wokke JH, Nillesen WM, de Visser M, Aronica E, Veldink JH, van den Berg LH. Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">71</span>:1500–5.</span> [<a href="/pubmed/18799786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18799786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.casari.1998.973">Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, Fernandez P, De Michele G, Filla A, Cocozza S, Marconi R, D&#x000fc;rr A, Fontaine B, Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. <span><span class="ref-journal">Cell. </span>1998;<span class="ref-vol">93</span>:973–83.</span> [<a href="/pubmed/9635427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9635427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.choquet.2016.1016">Choquet K, Tetreault M, Yang S, La Piana R, Dicaire MJ, Vanstone MR, Mathieu J, Bouchard JP, Rioux MF, Rouleau GA, Boycott KM, Majewski J, Brais B, et al.  SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases. <span><span class="ref-journal">Eur J Hum Genet. </span>2016;<span class="ref-vol">24</span>:1016–21.</span> [<a href="/pmc/articles/PMC5070891/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5070891</span></a>] [<a href="/pubmed/26626314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26626314</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.de_michele.1998.135">De Michele G, De Fusco M, Cavalcanti F, Filla A, Marconi R, Volpe G, Monticelli A, Ballabio A, Casari G, Cocozza S. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. <span><span class="ref-journal">Am J Hum Genet. </span>1998;<span class="ref-vol">63</span>:135–9.</span> [<a href="/pmc/articles/PMC1377251/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377251</span></a>] [<a href="/pubmed/9634528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9634528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.di_bella.2010.313">Di Bella D, Lazzaro F, Brusco A, Plumari M, Battaglia G, Pastore A, Finardi A, Cagnoli C, Tempia F, Frontali M, Veneziano L, Sacco T, Boda E, Brussino A, Bonn F, Castellotti B, Baratta S, Mariotti C, Gellera C, Fracasso V, Magri S, Langer T, Plevani P, Di Donato S, Muzi-Falconi M, Taroni F. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. <span><span class="ref-journal">Nature Genetics. </span>2010;<span class="ref-vol">42</span>:313–21.</span> [<a href="/pubmed/20208537" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20208537</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.elleuch.2006.654">Elleuch N, Depienne C, Benomar A, Hernandez AM, Ferrer X, Fontaine B, Grid D, Tallaksen CM, Zemmouri R, Stevanin G, Durr A, Brice A. Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">66</span>:654–9.</span> [<a href="/pubmed/16534102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16534102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.fink.2002.711">Fink JK. Hereditary spastic paraplegia. <span><span class="ref-journal">Neurol Clin. </span>2002;<span class="ref-vol">20</span>:711–26.</span> [<a href="/pubmed/12432827" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12432827</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.fink.2003.1045">Fink JK. The hereditary spastic paraplegias: nine genes and counting. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1045–9.</span> [<a href="/pubmed/12925358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12925358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.fu.2016.421">Fu F, Wu D, Qian C. The MicroRNA-224 inhibitor prevents neuronal apoptosis via targeting spastic paraplegia 7 after cerebral ischemia. <span><span class="ref-journal">J Mol Neurosci. </span>2016;<span class="ref-vol">59</span>:421–9.</span> [<a href="/pubmed/27165196" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27165196</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.hourani.2009.936">Hourani R, El-Hajj T, Barada WH, Hourani M, Yamout BI. MR imaging findings in autosomal recessive hereditary spastic paraplegia. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2009;<span class="ref-vol">30</span>:936–40.</span> [<a href="/pubmed/19193756" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19193756</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.kawano.2018.996">Kawano O, Masuda M, Takao T, Sakai H, Morishita Y, Hayashi T, Ueta T, Maeda T. The dosage and administration of long-term intrathecal baclofen therapy for severe spasticity of spinal origin. <span><span class="ref-journal">Spinal Cord. </span>2018;<span class="ref-vol">56</span>:996–9.</span> [<a href="/pubmed/29895878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29895878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.klebe.2012.2980">Klebe S, Depienne C, Gerber S, Challe G, Anheim M, Charles P, Fedirko E, Lejeune E, Cottineau J, Brusco A, Dollfus H, Chinnery PF, Mancini C, Ferrer X, Sole G, Dest&#x000e9;e A, Mayer JM, Fontaine B, de Seze J, Clanet M, Ollagnon E, Busson P, Cazeneuve C, Stevanin G, Kaplan J, Rozet JM, Brice A, Durr A. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:2980–93.</span> [<a href="/pmc/articles/PMC3470714/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3470714</span></a>] [<a href="/pubmed/23065789" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23065789</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.k_nig.2016.148">K&#x000f6;nig T, Tr&#x000f6;der SE, Bakka K, Korwitz A, Richter-Dennerlein R, Lampe PA, Patron M, M&#x000fc;hlmeister M, Guerrero-Castillo S, Brandt U, Decker T, Lauria I, Paggio A, Rizzuto R, Rugarli EI, De Stefani D, Langer T. The m-AAA protease associated with neurodegeneration limits MCU activity in mitochondria. <span><span class="ref-journal">Mol Cell. </span>2016;<span class="ref-vol">64</span>:148–62.</span> [<a href="/pubmed/27642048" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27642048</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.koppen.2009.4216">Koppen M, Bonn F, Ehses S, Langer T. Autocatalytic processing of m-AAA protease subunits in mitochondria. <span><span class="ref-journal">Mol Biol Cell. </span>2009;<span class="ref-vol">20</span>:4216–24.</span> [<a href="/pmc/articles/PMC2754935/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2754935</span></a>] [<a href="/pubmed/19656850" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19656850</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.kr_ger.2016.92">Kr&#x000fc;ger S, Battke F, Sprecher A, Munz M, Synofzik M, Schols L, Gasser T, Grehl T, Prudlo J, Biskup S. Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS cohort. <span><span class="ref-journal">Front Mol Neurosci. </span>2016;<span class="ref-vol">9</span>:92.</span> [<a href="/pmc/articles/PMC5061735/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5061735</span></a>] [<a href="/pubmed/27790088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27790088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.maltecca.2008.2827">Maltecca F, Aghaie A, Schroeder DG, Cassina L, Taylor BA, Phillips SJ, Malaguti M, Previtali S, Gu&#x000e9;net JL, Quattrini A, Cox GA, Casari G. The mitochondrial protease AFG3L2 is essential for axonal development. <span><span class="ref-journal">J Neurosci. </span>2008;<span class="ref-vol">28</span>:2827–36.</span> [<a href="/pmc/articles/PMC6670688/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6670688</span></a>] [<a href="/pubmed/18337413" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18337413</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.mcdermott.2001.467">McDermott CJ, Dayaratne RK, Tomkins J, Lusher ME, Lindsey JC, Johnson MA, Casari G, Turnbull DM, Bushby K, Shaw PJ. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">56</span>:467–71.</span> [<a href="/pubmed/11222789" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11222789</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.melo.2015.6877">Melo US, Macedo-Souza LI, Figueiredo T, Muotri AR, Gleeson JG, Coux G, Armas P, Calcaterra NB, Kitajima JP, Amorim S, Olavio TR, Griesi-Oliveira K, Coatti GC, Rocha CRR, Martins-Pinheiro M, Menck CFM, Zaki MS, Kok F, Zatz M, Santos S. Overexpression of KLC2 due to a homozygous deletion in the non-coding region causes SPOAN syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2015;<span class="ref-vol">24</span>:6877–85.</span> [<a href="/pmc/articles/PMC6296331/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6296331</span></a>] [<a href="/pubmed/26385635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26385635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.nardone.2003.234">Nardone R, Tezzon F. Transcranial magnetic stimulation study in hereditary spastic paraparesis. <span><span class="ref-journal">Eur Neurol. </span>2003;<span class="ref-vol">49</span>:234–7.</span> [<a href="/pubmed/12736541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12736541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.nielsen.2001.335">Nielsen JE, Jennum P, Fenger K, S&#x000f8;rensen SA, Fuglsang-Frederiksen A. Increased intracortical facilitation in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p. <span><span class="ref-journal">Eur J Neurol. </span>2001;<span class="ref-vol">8</span>:335.</span> [<a href="/pubmed/11422430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11422430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.pfeffer.2014.1323">Pfeffer G, Gorman GS, Griffin H, Kurzawa-Akanbi M, Blakely EL, Wilson I, Sitarz K, Moore D, Murphy JL, Alston CL, Pyle A, Coxhead J, Payne B, Gorrie GH, Longman C, Hadjivassiliou M, McConville J, Dick D, Imam I, Hilton D, Norwood F, Baker MR, Jaiser SR, Yu-Wai-Man P, Farrell M, McCarthy A, Lynch T, McFarland R, Schaefer AM, Turnbull DM, Horvath R, Taylor RW, Chinnery PF. Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:1323–36.</span> [<a href="/pmc/articles/PMC3999722/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3999722</span></a>] [<a href="/pubmed/24727571" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24727571</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.pfeffer.2015.1174">Pfeffer G, Pyle A, Griffin H, Miller J, Wilson V, Turnbull L, Fawcett K, Sims D, Eglon G, Hadjivassiliou M, Horvath R, N&#x000e9;meth A, Chinnery PF. SPG7 mutations are a common cause of undiagnosed ataxia. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:1174–6.</span> [<a href="/pmc/articles/PMC4371411/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4371411</span></a>] [<a href="/pubmed/25681447" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25681447</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.salinas.2008.1127">Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. <span><span class="ref-journal">Lancet Neurol. </span>2008;<span class="ref-vol">7</span>:1127–38.</span> [<a href="/pubmed/19007737" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19007737</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.s_nchezferrero.2013.257">S&#x000e1;nchez-Ferrero E, Coto E, Beetz C, G&#x000e1;mez J, Corao AI, D&#x000ed;az M, Esteban J, del Castillo E, Moris G, Infante J, Men&#x000e9;ndez M, Pascual-Pascual SI, L&#x000f3;pez de Muna&#x000ed;n A, Garcia-Barcina MJ, Alvarez V, et al.  SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">83</span>:257–62.</span> [<a href="/pubmed/22571692" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22571692</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.sch_le.2006.430">Sch&#x000fc;le R, Holland-Letz T, Klimpe S, Kassubek J, Klopstock T, Mall V, Otto S, Winner B, Sch&#x000f6;ls L. The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:430–4.</span> [<a href="/pubmed/16894103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16894103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.shanmughapriya.2015.47">Shanmughapriya S, Rajan S, Hoffman NE, Higgins AM, Tomar D, Nemani N, Hines KJ, Smith DJ, Eguchi A, Vallem S, Shaikh F, Cheung M, Leonard NJ, Stolakis RS, Wolfers MP, Ibetti J, Chuprun JK, Jog NR, Houser SR, Koch WJ, Elrod JW, Madesh M. SPG7 is an essential and conserved component of the mitochondrial permeability transition pore. <span><span class="ref-journal">Mol Cell. </span>2015;<span class="ref-vol">60</span>:47–62.</span> [<a href="/pmc/articles/PMC4592475/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4592475</span></a>] [<a href="/pubmed/26387735" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26387735</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.synofzik.2017.332">Synofzik M, Schule R. Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways. <span><span class="ref-journal">Mov Disord. </span>2017;<span class="ref-vol">32</span>:332–45.</span> [<a href="/pmc/articles/PMC6287914/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6287914</span></a>] [<a href="/pubmed/28195350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28195350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.tzoulis.2008.1142">Tzoulis C, Denora PS, Santorelli FM, Bindoff LA. Hereditary spastic paraplegia caused by the novel mutation 1047insC in the SPG7 gene. <span><span class="ref-journal">J Neurol. </span>2008;<span class="ref-vol">255</span>:1142–4.</span> [<a href="/pubmed/18563470" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18563470</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.van_gassen.2012.2994">van Gassen KL, van der Heijden CD, de Bot ST, den Dunnen WF, van den Berg LH, Verschuuren-Bemelmans CC, Kremer HP, Veldink JH, Kamsteeg EJ, Scheffer H, van de Warrenburg BP. Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:2994–3004.</span> [<a href="/pubmed/22964162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22964162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.warnecke.2010.413">Warnecke T, Duning T, Schirmacher A, Mohammadi S, Schwindt W, Lohmann H, Dziewas R, Deppe M, Ringelstein EB, Young P. A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects. <span><span class="ref-journal">Mov Disord. </span>2010;<span class="ref-vol">25</span>:413–20.</span> [<a href="/pubmed/20108356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20108356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.wedding.2014.e86340">Wedding IM, Koht J, Tran GT, Misceo D, Selmer KK, Holmgren A, Frengen E, Bindoff L, Tallaksen CM, Tzoulis C. Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>:e86340.</span> [<a href="/pmc/articles/PMC3899233/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3899233</span></a>] [<a href="/pubmed/24466038" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24466038</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.wilkinson.2004.973">Wilkinson PA, Crosby AH, Turner C, Bradley LJ, Ginsberg L, Wood NW, Schapira AH, Warner TT. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. <span><span class="ref-journal">Brain. </span>2004;<span class="ref-vol">127</span>:973–80.</span> [<a href="/pubmed/14985266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14985266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.yahikozawa.2015.15012">Yahikozawa H, Yoshida K, Sato S, Hanyu N, Doi H, Miyatake S, Matsumoto N. Predominant cerebellar phenotype in spastic paraplegia 7 (SPG7). <span><span class="ref-journal">Hum Genome Var. </span>2015;<span class="ref-vol">2</span>:15012.</span> [<a href="/pmc/articles/PMC4785587/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4785587</span></a>] [<a href="/pubmed/27081526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27081526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.yang.2016.e60">Yang Y, Zhang L, Lynch DR, Lukas T, Ahmeti K, Sleiman PM, Ryan E, Schadt KA, Newman JH, Deng HX, Siddique N, Siddique T. Compound heterozygote mutations in SPG7 in a family with adult-onset primary lateral sclerosis. <span><span class="ref-journal">Neurol Genet. </span>2016;<span class="ref-vol">2</span>:e60.</span> [<a href="/pmc/articles/PMC4830188/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4830188</span></a>] [<a href="/pubmed/27123479" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27123479</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="spg7.REF.z_chner.2006.276">Z&#x000fc;chner S, De Jonghe P, Jordanova A, Claeys KG, Guergueltcheva V, Cherninkova S, Hamilton SR, Van Stavern G, Krajewski KM, Stajich J, Tournev I, Verhoeven K, Langerhorst CT, de Visser M, Baas F, Bird T, Timmerman V, Shy M, Vance JM. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:276–81.</span> [<a href="/pubmed/16437557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16437557</span></a>]</div></li></ul></div></div><div id="spg7.Chapter_Notes"><h2 id="_spg7_Chapter_Notes_">Chapter Notes</h2><div id="spg7.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 October 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 December 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 February 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>24 August 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>7 March 2005 (gc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1107</span><span class="label">PMID: <a href="/pubmed/20301286" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301286</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spg4/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/spg8/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1107&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1107/?report=reader">PubReader</a></li><li><a href="/books/NBK1107/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1107" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1107" style="display:none" title="Cite this Page"><div class="bk_tt">Casari G, Marconi R. Spastic Paraplegia 7. 2006 Aug 24 [Updated 2018 Oct 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1107/pdf/Bookshelf_NBK1107.pdf">PDF version of this page</a> (448K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#spg7.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#spg7.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#spg7.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#spg7.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#spg7.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#spg7.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#spg7.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#spg7.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#spg7.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#spg7.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#spg7.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6687[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SPG7</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1483704" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1483704" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1483704" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1483704" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23065789" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.</a><span class="source">[Brain. 2012]</span><div class="brieflinkpop offscreen_noflow">Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Klebe S, Depienne C, Gerber S, Challe G, Anheim M, Charles P, Fedirko E, Lejeune E, Cottineau J, Brusco A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain. 2012 Oct; 135(Pt 10):2980-93. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301432" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> ARSACS</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> ARSACS<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Vermeer S, van de Warrenburg BP, Kamsteeg EJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301389" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 11</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 11<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Stevanin G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301458" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Friedreich Ataxia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Friedreich Ataxia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bidichandani SI, Delatycki MB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301286" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301286" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0415b2dde089116905d9c2">Spastic Paraplegia 7 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spastic Paraplegia 7 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:06:42-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B4E12E03FA791000000000A2F03B8&amp;ncbi_session=CE8B4E12E0415B11_2607SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1107%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1107&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1107/&amp;ncbi_pagename=Spastic Paraplegia 7 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B4E12E0415B11_2607SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>